InflaRx N.V.
IFRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708688
No open-market purchases or sales by InflaRx N.V. insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $218.1M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +27 vs. previous quarter
- 62
- 13F valueReported value at the end of Q2 2026
- $218.1M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding IFRX, Q2 2026
No superinvestor reported holding IFRX at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by InflaRx N.V. insiders from Form 4, newest first.
No open-market purchases or sales by InflaRx N.V. insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in InflaRx N.V. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Suvretta Capital Management, LLC | 22,933,910 | $51.4M | 1.08% | +15,000,000+189.1% | Added |
| TCG Crossover Management, LLC | 14,500,000 | $32.5M | 0.78% | +14,500,000 | New |
| FMR LLC | 8,163,341 | $18.3M | 0.00% | +8,163,341 | New |
| Commodore Capital LP | 7,300,000 | $16.4M | 0.97% | +7,300,000 | New |
| Kalehua Capital Management LLC | 5,795,538 | $13.0M | 4.14% | +5,795,538 | New |
| Spruce Street Capital LP | 5,352,198 | $12.0M | 2.35% | +5,352,198 | New |
| 683 Capital Management, LLC | 5,065,000 | $11.3M | 1.04% | +1,750,000+52.8% | Added |
| Farallon Capital Management, L.L.C. | 3,325,000 | $7.45M | 0.04% | +3,325,000 | New |
| StemPoint Capital LP | 3,228,255 | $7.23M | 1.25% | +3,228,255 | New |
| Great Point Partners LLC | 3,046,557 | $6.82M | 1.61% | +3,046,557 | New |